Sodium-glucose cotransporter 2 inhibitors (SGLT2i): their role in cardiometabolic risk management by Katsiki, N, Mikhailidis, D, Theodorakis, M

Modeling the oral glucose tolerance test in normal and impaired glucose tolerant states: a population approach by Theodorakis, M, Katsiki, N, Arampatzi, K, Chrousos, G